MANGALAMPharmaceuticals
Mangalam Drugs and Organics Ltd — Balance Sheet
₹27.15
-4.91%
Mangalam Drugs and Organics Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Common Stock | 15.83 Cr | 15.83 Cr | 15.83 Cr | 15.83 Cr | — |
| Total Liabilities Net Minority Interest | 217.44 Cr | 197.91 Cr | 207.67 Cr | 177.86 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 25.84 Cr | 33.85 Cr | 42.32 Cr | 47.75 Cr | — |
| Other Non Current Liabilities | 4.28 Cr | 1.93 Cr | -1000.00 | 0.23 Cr | — |
| Non Current Deferred Taxes Liabilities | 9.82 Cr | 12.09 Cr | 14.52 Cr | 13.49 Cr | — |
| Long Term Debt And Capital Lease Obligation | 11.75 Cr | 18.49 Cr | 25.51 Cr | 30.32 Cr | — |
| Long Term Capital Lease Obligation | 2.52 Cr | 5.13 Cr | 6.74 Cr | 5.21 Cr | — |
| Long Term Debt | 9.23 Cr | 13.35 Cr | 18.77 Cr | 25.10 Cr | — |
| Current Liabilities | 191.60 Cr | 164.06 Cr | 165.36 Cr | 130.11 Cr | — |
| Other Current Liabilities | 13.95 Cr | 0.68 Cr | 0.60 Cr | 1.39 Cr | — |
| Current Debt And Capital Lease Obligation | 77.42 Cr | 88.50 Cr | 63.04 Cr | 57.59 Cr | — |
| Current Capital Lease Obligation | 5.48 Cr | 5.41 Cr | 7.21 Cr | 3.88 Cr | — |
| Current Debt | 71.94 Cr | 83.09 Cr | 55.83 Cr | 53.71 Cr | — |
| Current Provisions | 1.10 Cr | 0.99 Cr | 1.34 Cr | 1.00 Cr | — |
| Payables | 92.07 Cr | 66.25 Cr | 97.49 Cr | 56.87 Cr | — |
| Total Tax Payable | 0.92 Cr | 0.00 | 0.38 Cr | 2.27 Cr | — |
| Accounts Payable | 91.15 Cr | 66.16 Cr | 97.07 Cr | 54.55 Cr | — |
| Total Assets | 366.42 Cr | 333.70 Cr | 359.63 Cr | 328.43 Cr | — |
| Total Non Current Assets | 167.44 Cr | 157.70 Cr | 153.04 Cr | 143.38 Cr | — |
| Other Non Current Assets | 1.92 Cr | — | 0.88 Cr | 2.41 Cr | -2000.00 |
| Investmentin Financial Assets | 0.10 Cr | 44000.00 | 43000.00 | 43000.00 | — |
| Available For Sale Securities | 0.10 Cr | 26000.00 | 25000.00 | 25000.00 | — |
| Goodwill And Other Intangible Assets | 31.83 Cr | 28.49 Cr | 18.24 Cr | 13.78 Cr | — |
| Other Intangible Assets | 31.83 Cr | 28.49 Cr | 18.24 Cr | 13.78 Cr | — |
| Net PPE | 133.60 Cr | 129.12 Cr | 134.50 Cr | 129.29 Cr | — |
| Gross PPE | 133.60 Cr | 229.38 Cr | 224.86 Cr | 211.01 Cr | — |
| Construction In Progress | 0.00 | 2.20 Cr | 7.28 Cr | 2.59 Cr | — |
| Other Properties | 133.60 Cr | 38.86 Cr | 35.13 Cr | 26.29 Cr | — |
| Current Assets | 198.98 Cr | 176.00 Cr | 206.58 Cr | 185.03 Cr | — |
| Other Current Assets | 11.94 Cr | 0.08 Cr | 1.75 Cr | 1.74 Cr | — |
| Inventory | 138.80 Cr | 123.64 Cr | 137.47 Cr | 117.11 Cr | — |
| Other Receivables | 1.09 Cr | 1.17 Cr | 0.05 Cr | 0.04 Cr | — |
| Accounts Receivable | 39.07 Cr | 27.94 Cr | 46.53 Cr | 46.49 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 8.07 Cr | 1.19 Cr | 2.69 Cr | 1.95 Cr | — |
| Other Short Term Investments | 5.49 Cr | 76000.00 | 76000.00 | 76000.00 | — |
| Cash And Cash Equivalents | 2.59 Cr | 1.18 Cr | 2.68 Cr | 1.95 Cr | — |
| Ordinary Shares Number | 1.58 Cr | 1.58 Cr | 1.58 Cr | 1.58 Cr | — |
| Share Issued | 1.58 Cr | 1.58 Cr | 1.58 Cr | 1.58 Cr | — |
| Net Debt | 78.58 Cr | 95.27 Cr | 71.91 Cr | 76.87 Cr | — |
| Total Debt | 89.17 Cr | 106.99 Cr | 88.55 Cr | 87.90 Cr | — |
| Tangible Book Value | 117.15 Cr | 107.31 Cr | 133.72 Cr | 136.78 Cr | — |
| Invested Capital | 230.15 Cr | 232.24 Cr | 226.55 Cr | 229.38 Cr | — |
| Working Capital | 7.38 Cr | 11.94 Cr | 41.23 Cr | 54.92 Cr | — |
| Net Tangible Assets | 117.15 Cr | 107.31 Cr | 133.72 Cr | 136.78 Cr | — |
| Capital Lease Obligations | 8.00 Cr | 10.54 Cr | 13.95 Cr | 9.09 Cr | — |
| Common Stock Equity | 148.98 Cr | 135.79 Cr | 151.96 Cr | 150.56 Cr | — |
| Total Capitalization | 158.21 Cr | 149.15 Cr | 170.72 Cr | 175.66 Cr | — |
| Total Equity Gross Minority Interest | 148.98 Cr | 135.79 Cr | 151.96 Cr | 150.56 Cr | — |
| Stockholders Equity | 148.98 Cr | 135.79 Cr | 151.96 Cr | 150.56 Cr | — |
| Other Equity Interest | 133.15 Cr | 119.96 Cr | 136.13 Cr | 134.73 Cr | — |
| Capital Stock | 15.83 Cr | 15.83 Cr | 15.83 Cr | 15.83 Cr | — |
| Non Current Accrued Expenses | — | 1.34 Cr | — | 3.71 Cr | — |
| Other Payable | — | 0.09 Cr | 0.04 Cr | 0.05 Cr | 0.06 Cr |
| Non Current Prepaid Assets | — | 0.09 Cr | 0.31 Cr | 0.31 Cr | 2.46 Cr |
| Held To Maturity Securities | — | 18000.00 | 18000.00 | 18000.00 | 18000.00 |
| Accumulated Depreciation | — | -100.26 Cr | -90.36 Cr | -81.72 Cr | -73.43 Cr |
| Machinery Furniture Equipment | — | 149.87 Cr | 144.70 Cr | 144.05 Cr | 130.40 Cr |
| Buildings And Improvements | — | 37.32 Cr | 37.20 Cr | 37.54 Cr | 33.39 Cr |
| Land And Improvements | — | 1.13 Cr | 0.54 Cr | 0.54 Cr | 0.54 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Prepaid Assets | — | 21.61 Cr | 17.74 Cr | 17.71 Cr | 16.49 Cr |
| Finished Goods | — | 24.22 Cr | 43.21 Cr | 26.77 Cr | 14.50 Cr |
| Work In Process | — | 74.35 Cr | 64.45 Cr | 38.73 Cr | 17.26 Cr |
| Raw Materials | — | 25.08 Cr | 29.80 Cr | 51.60 Cr | 26.83 Cr |
| Taxes Receivable | — | 0.37 Cr | 0.37 Cr | 0.00 | 2.17 Cr |
| Cash Equivalents | — | 0.39 Cr | 2.22 Cr | 0.52 Cr | 0.51 Cr |
| Cash Financial | — | 0.79 Cr | 0.46 Cr | 1.43 Cr | 0.08 Cr |
| Retained Earnings | — | 86.73 Cr | 102.96 Cr | 101.57 Cr | 81.79 Cr |
| Additional Paid In Capital | — | 22.38 Cr | 22.38 Cr | 22.38 Cr | 22.38 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | — | 2.29 Cr | 3.94 Cr | — |
| Other Inventories | — | — | — | -1000.00 | -1000.00 |
| Allowance For Doubtful Accounts Receivable | — | — | — | — | 0.00 |
| Gross Accounts Receivable | — | — | — | — | 53.59 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Mangalam Drugs and Organics Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.